Zimmer Biomet Holdings, Inc. Share Price
Equities
ZBH
US98956P1021
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.75 USD | -1.62% |
|
-2.12% | -12.19% |
| Capitalization | 1.87TCr 1.61TCr 1.51TCr 1.4TCr 2.59TCr 1,68500Cr 2.82TCr 18TCr 6.81TCr 80TCr 7.01TCr 6.86TCr 2,91400Cr | P/E ratio 2025 * |
20.4x | P/E ratio 2026 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.47TCr 2.13TCr 2TCr 1.86TCr 3.43TCr 2,23000Cr 3.74TCr 23TCr 9.02TCr 1,05300Cr 9.29TCr 9.09TCr 3,85800Cr | EV / Sales 2025 * |
3.01x | EV / Sales 2026 * | 2.72x |
| Free-Float |
62.74% | Yield 2025 * |
1.06% | Yield 2026 * | 1.08% |
Last Transcript: Zimmer Biomet Holdings, Inc.
| 1 day | -1.62% | ||
| 1 week | -2.12% | ||
| Current month | -4.89% | ||
| 1 month | +4.80% | ||
| 3 months | -11.42% | ||
| 6 months | +0.40% | ||
| Current year | -12.19% |
| 1 week | 91.46 |  | 95.26 |
| 1 month | 86.51 | | 98.34 |
| Current year | 85.33 | | 114.44 |
| 1 year | 85.33 | | 114.44 |
| 3 years | 85.33 | | 149.25 |
| 5 years | 85.33 | | 180.36 |
| 10 years | 74.37 | | 180.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ivan Tornos
CEO | Chief Executive Officer | 49 | 22/08/2023 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 56 | 01/07/2019 |
Nitin Goyal
CTO | Chief Tech/Sci/R&D Officer | - | 07/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Arthur Higgins
BRD | Director/Board Member | 69 | 12/02/2007 |
Robert Hagemann
BRD | Director/Board Member | 68 | 13/03/2008 |
Betsy Bernard
BRD | Director/Board Member | 69 | 01/01/2009 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.77% | 26 M€ | +11.67% | - |
| 0.72% | 2 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.62% | -2.12% | -14.14% | -26.30% | 1.87TCr | |
| -2.39% | -4.62% | +5.61% | +14.19% | 22TCr | |
| -0.10% | -2.01% | +20.53% | +30.17% | 13TCr | |
| -0.54% | -6.19% | +38.79% | +98.18% | 6.59TCr | |
| -1.77% | -1.21% | -13.87% | -23.58% | 5.54TCr | |
| -0.67% | +0.49% | +17.32% | +71.10% | 5.2TCr | |
| -0.71% | -0.56% | +21.08% | +37.38% | 2.58TCr | |
| +0.20% | +3.31% | -15.57% | -46.51% | 2.55TCr | |
| -0.84% | +1.63% | +17.63% | -33.20% | 2.41TCr | |
| -1.01% | -2.11% | -23.86% | +18.10% | 2.25TCr | |
| Average | -0.94% | -1.28% | +5.35% | +13.95% | 6.37TCr | |
| Weighted average by Cap. | -1.23% | -2.57% | +9.96% | +23.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 820.97Cr 706.69Cr 663.41Cr 616.69Cr 1.14TCr 74TCr 1.24TCr 7.73TCr 2.99TCr 35TCr 3.08TCr 3.02TCr 1,28000Cr | 863.41Cr 743.23Cr 697.72Cr 648.58Cr 1.2TCr 78TCr 1.3TCr 8.13TCr 3.15TCr 37TCr 3.24TCr 3.17TCr 1,34600Cr |
| Net income | 91Cr 78Cr 73Cr 68Cr 125.86Cr 8.19TCr 137.31Cr 855.95Cr 331.45Cr 3.87TCr 341.15Cr 333.85Cr 14TCr | 112.91Cr 97Cr 91Cr 85Cr 156.34Cr 10TCr 170.57Cr 1.06TCr 411.73Cr 4.81TCr 423.77Cr 414.71Cr 18TCr |
| Net Debt | 605.4Cr 521.13Cr 489.22Cr 454.77Cr 838.26Cr 55TCr 914.52Cr 5.7TCr 2.21TCr 26TCr 2.27TCr 2.22TCr 94TCr | 476.51Cr 410.18Cr 385.06Cr 357.95Cr 659.79Cr 43TCr 719.82Cr 4.49TCr 1.74TCr 20TCr 1.79TCr 1.75TCr 74TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 92.75 $ | -1.62% | 30,79,063 |
| 05/25/05 | 94.28 $ | +1.20% | 23,05,924 |
| 04/25/04 | 93.16 $ | +0.06% | 21,77,469 |
| 03/25/03 | 93.10 $ | -1.10% | 19,84,679 |
| 02/25/02 | 94.14 $ | -0.65% | 15,36,359 |
Delayed Quote Nyse, December 09, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZBH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition